Type 2 diabetes-related health measures during the initial COVID-19 surge at an academic internal medicine practice

Prim Care Diabetes. 2024 Apr;18(2):246-247. doi: 10.1016/j.pcd.2024.01.007. Epub 2024 Jan 25.

Abstract

The COVID-19 pandemic disrupted chronic disease management in the United States and across the world. This study reports minimal effects of the initial COVID-19 surge on body mass index, blood pressure, cholesterol, and blood glucose control in ambulatory general internal medicine patients with Type 2 diabetes at a single academic center.

Keywords: COVID-19; Chronic disease management; Primary care; Type 2 diabetes.

MeSH terms

  • Blood Pressure
  • COVID-19* / epidemiology
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Internal Medicine
  • Pandemics
  • United States